| 10.1 |
30.2 |
GO:0048627 |
myoblast development(GO:0048627) |
| 9.8 |
39.4 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 9.3 |
27.8 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 8.1 |
24.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 7.9 |
31.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 6.8 |
34.1 |
GO:0070178 |
D-serine metabolic process(GO:0070178) |
| 6.7 |
20.1 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 6.4 |
19.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 6.4 |
31.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 6.2 |
18.6 |
GO:0006175 |
adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
| 6.1 |
36.7 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 5.9 |
23.6 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 5.8 |
34.6 |
GO:1902998 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 5.7 |
17.2 |
GO:0046491 |
L-methylmalonyl-CoA metabolic process(GO:0046491) |
| 5.7 |
17.2 |
GO:1903000 |
regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 5.7 |
17.0 |
GO:0021682 |
nerve maturation(GO:0021682) |
| 5.5 |
33.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 5.2 |
15.6 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 5.2 |
15.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 5.0 |
5.0 |
GO:0015744 |
succinate transport(GO:0015744) |
| 5.0 |
19.9 |
GO:0010901 |
regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 4.6 |
46.3 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) |
| 4.6 |
13.9 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 4.5 |
18.2 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 4.4 |
13.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 4.1 |
12.4 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 4.0 |
16.2 |
GO:1901373 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
| 4.0 |
12.0 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 3.9 |
70.6 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 3.9 |
27.4 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 3.8 |
38.5 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 3.7 |
11.0 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 3.6 |
32.6 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 3.6 |
10.7 |
GO:0006571 |
tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
| 3.6 |
10.7 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 3.4 |
17.0 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 3.4 |
13.5 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
| 3.4 |
10.1 |
GO:0042128 |
nitrate assimilation(GO:0042128) |
| 3.3 |
16.5 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 3.3 |
16.5 |
GO:0006548 |
histidine catabolic process(GO:0006548) |
| 3.3 |
19.6 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 3.2 |
9.7 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 3.1 |
15.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 3.0 |
3.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 3.0 |
9.1 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 3.0 |
12.1 |
GO:0015755 |
fructose transport(GO:0015755) |
| 3.0 |
12.1 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 3.0 |
12.0 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 3.0 |
9.0 |
GO:0033306 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 3.0 |
11.8 |
GO:0034757 |
negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
| 2.9 |
8.7 |
GO:0046203 |
spermidine catabolic process(GO:0046203) |
| 2.9 |
11.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 2.9 |
8.6 |
GO:0006867 |
asparagine transport(GO:0006867) positive regulation of glutamine transport(GO:2000487) |
| 2.8 |
31.3 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.8 |
11.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 2.8 |
8.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 2.7 |
10.9 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 2.7 |
10.8 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) |
| 2.7 |
8.1 |
GO:0006530 |
asparagine catabolic process(GO:0006530) |
| 2.7 |
16.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 2.7 |
31.9 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 2.6 |
10.6 |
GO:0080163 |
regulation of protein serine/threonine phosphatase activity(GO:0080163) |
| 2.6 |
18.3 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 2.5 |
10.2 |
GO:0034034 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 2.5 |
7.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 2.5 |
7.4 |
GO:1901053 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 2.5 |
7.4 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 2.4 |
4.9 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 2.4 |
12.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.4 |
4.7 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 2.3 |
4.7 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 2.3 |
11.7 |
GO:0090467 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 2.3 |
6.8 |
GO:0090320 |
chylomicron assembly(GO:0034378) regulation of chylomicron remnant clearance(GO:0090320) |
| 2.2 |
24.4 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 2.2 |
4.4 |
GO:0052805 |
imidazole-containing compound catabolic process(GO:0052805) |
| 2.2 |
6.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 2.2 |
8.7 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 2.2 |
6.5 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 2.2 |
21.7 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 2.2 |
6.5 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 2.2 |
8.6 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 2.1 |
8.5 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) |
| 2.1 |
6.4 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 2.1 |
10.5 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 2.1 |
2.1 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 2.1 |
2.1 |
GO:1903540 |
neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 2.1 |
4.1 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 2.1 |
10.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 2.1 |
6.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 2.0 |
8.2 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 2.0 |
16.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 2.0 |
16.3 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 2.0 |
8.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.0 |
6.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 2.0 |
6.0 |
GO:1904582 |
positive regulation of intracellular mRNA localization(GO:1904582) |
| 2.0 |
13.9 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 2.0 |
5.9 |
GO:0031104 |
dendrite regeneration(GO:0031104) |
| 2.0 |
13.7 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.9 |
11.6 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.9 |
9.7 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.9 |
7.7 |
GO:0015770 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.9 |
5.7 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.9 |
5.7 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 1.9 |
5.7 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 1.9 |
1.9 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 1.9 |
7.5 |
GO:0050823 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 1.9 |
5.6 |
GO:1903920 |
positive regulation of actin filament severing(GO:1903920) |
| 1.9 |
11.1 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 1.8 |
5.5 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 1.8 |
1.8 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 1.8 |
1.8 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 1.8 |
5.5 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 1.8 |
9.1 |
GO:0042197 |
chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.8 |
5.4 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 1.8 |
5.4 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.8 |
5.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.8 |
5.4 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.8 |
16.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.8 |
10.7 |
GO:0043102 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 1.8 |
10.6 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 1.8 |
7.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.8 |
14.1 |
GO:0009074 |
tryptophan catabolic process(GO:0006569) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 1.8 |
5.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.8 |
5.3 |
GO:0032416 |
negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 1.8 |
19.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 1.7 |
8.7 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.7 |
12.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 1.7 |
12.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.7 |
11.9 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 1.7 |
5.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.7 |
6.8 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 1.7 |
11.9 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.7 |
5.1 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.7 |
5.1 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 1.7 |
5.0 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 1.7 |
3.3 |
GO:0046724 |
oxalic acid secretion(GO:0046724) |
| 1.7 |
5.0 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 1.7 |
8.3 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 1.7 |
10.0 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 1.7 |
6.6 |
GO:0009744 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 1.6 |
4.9 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
| 1.6 |
3.3 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.6 |
47.7 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 1.6 |
4.9 |
GO:0034552 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.6 |
4.9 |
GO:0061646 |
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization(GO:0061646) |
| 1.6 |
6.4 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 1.6 |
17.5 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.6 |
3.2 |
GO:0070054 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 1.6 |
3.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 1.6 |
17.2 |
GO:1903797 |
positive regulation of inorganic anion transmembrane transport(GO:1903797) |
| 1.6 |
4.7 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.6 |
14.0 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 1.6 |
4.7 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.5 |
10.8 |
GO:0015864 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 1.5 |
6.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.5 |
7.7 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 1.5 |
4.6 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 1.5 |
13.7 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 1.5 |
4.5 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 1.5 |
4.5 |
GO:0034959 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.5 |
15.0 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 1.5 |
25.5 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 1.5 |
4.5 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 1.5 |
3.0 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.5 |
4.5 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.5 |
8.9 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.5 |
4.4 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 1.5 |
2.9 |
GO:0022009 |
central nervous system vasculogenesis(GO:0022009) |
| 1.5 |
5.8 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.5 |
4.4 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 1.5 |
1.5 |
GO:0060336 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 1.4 |
7.2 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 1.4 |
10.1 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 1.4 |
13.0 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 1.4 |
4.3 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.4 |
4.3 |
GO:0090367 |
negative regulation of mRNA modification(GO:0090367) |
| 1.4 |
4.3 |
GO:0021589 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.4 |
8.5 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.4 |
14.2 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 1.4 |
22.7 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 1.4 |
2.8 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 1.4 |
18.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 1.4 |
8.4 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 1.4 |
1.4 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 1.4 |
2.8 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.4 |
19.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 1.4 |
5.5 |
GO:0009078 |
alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
| 1.4 |
4.1 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 1.4 |
4.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 1.4 |
5.4 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 1.3 |
20.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.3 |
5.4 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 1.3 |
1.3 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 1.3 |
13.4 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.3 |
5.3 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 1.3 |
1.3 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 1.3 |
3.9 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 1.3 |
5.2 |
GO:0006499 |
N-terminal protein myristoylation(GO:0006499) |
| 1.3 |
5.2 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 1.3 |
3.9 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 1.3 |
3.9 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 1.3 |
11.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.3 |
2.5 |
GO:0002071 |
glandular epithelial cell maturation(GO:0002071) |
| 1.3 |
11.5 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.3 |
8.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.3 |
3.8 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 1.3 |
3.8 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 1.2 |
11.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 1.2 |
7.4 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 1.2 |
3.7 |
GO:0015734 |
beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
| 1.2 |
3.7 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 1.2 |
1.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.2 |
29.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 1.2 |
3.7 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.2 |
6.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 1.2 |
6.0 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 1.2 |
4.8 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 1.2 |
1.2 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 1.2 |
7.1 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 1.2 |
3.5 |
GO:0072347 |
response to anesthetic(GO:0072347) |
| 1.2 |
4.7 |
GO:1901026 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.2 |
9.3 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 1.2 |
2.3 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 1.2 |
18.6 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 1.2 |
2.3 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 1.1 |
20.6 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.1 |
1.1 |
GO:2000451 |
positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 1.1 |
3.4 |
GO:0072193 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 1.1 |
10.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.1 |
10.1 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.1 |
6.8 |
GO:0018992 |
germ-line sex determination(GO:0018992) |
| 1.1 |
5.6 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 1.1 |
5.6 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.1 |
3.4 |
GO:0014732 |
skeletal muscle atrophy(GO:0014732) |
| 1.1 |
3.3 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 1.1 |
4.4 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 1.1 |
2.2 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 1.1 |
3.3 |
GO:0002380 |
immunoglobulin secretion involved in immune response(GO:0002380) |
| 1.1 |
7.7 |
GO:0001757 |
somite specification(GO:0001757) |
| 1.1 |
8.8 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 1.1 |
4.4 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 1.1 |
21.9 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 1.1 |
3.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 1.1 |
3.3 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 1.1 |
5.5 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 1.1 |
2.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 1.1 |
57.5 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 1.1 |
3.2 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 1.1 |
16.2 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 1.1 |
5.4 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 1.1 |
3.2 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.1 |
5.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 1.1 |
3.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 |
3.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.1 |
4.3 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 1.1 |
13.9 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 1.1 |
6.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.1 |
7.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.1 |
1.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 1.1 |
7.4 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 1.1 |
2.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 1.1 |
4.2 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 1.0 |
4.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.0 |
3.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.0 |
3.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 1.0 |
6.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 1.0 |
4.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 1.0 |
1.0 |
GO:0060399 |
regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.0 |
4.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 1.0 |
6.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.0 |
2.0 |
GO:2000388 |
regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
| 1.0 |
5.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 |
15.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.0 |
14.2 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 1.0 |
11.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 1.0 |
3.0 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.0 |
6.0 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 1.0 |
4.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.0 |
5.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.0 |
5.0 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 1.0 |
3.0 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 1.0 |
2.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 1.0 |
2.9 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 1.0 |
6.9 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.0 |
11.7 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 1.0 |
2.9 |
GO:0009732 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 1.0 |
3.9 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 1.0 |
2.9 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.0 |
4.8 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
| 1.0 |
1.9 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 1.0 |
1.0 |
GO:0072198 |
mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 1.0 |
2.9 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.0 |
3.9 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.0 |
7.7 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 1.0 |
1.9 |
GO:0009750 |
response to fructose(GO:0009750) |
| 1.0 |
10.5 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 1.0 |
4.8 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.0 |
1.9 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 0.9 |
64.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.9 |
9.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.9 |
3.8 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.9 |
2.8 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.9 |
3.8 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.9 |
1.9 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.9 |
0.9 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.9 |
1.9 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.9 |
40.2 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.9 |
4.6 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.9 |
3.7 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 |
1.9 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.9 |
2.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.9 |
3.7 |
GO:0061625 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.9 |
15.7 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.9 |
4.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.9 |
22.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.9 |
0.9 |
GO:0035332 |
positive regulation of hippo signaling(GO:0035332) |
| 0.9 |
2.7 |
GO:0008358 |
oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.9 |
4.5 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.9 |
9.0 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.9 |
7.2 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.9 |
5.4 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 0.9 |
5.4 |
GO:0045905 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.9 |
0.9 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.9 |
3.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.9 |
2.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.9 |
9.7 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.9 |
4.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.9 |
7.9 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.9 |
1.8 |
GO:2001055 |
positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
| 0.9 |
2.6 |
GO:1904766 |
negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
| 0.9 |
3.5 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.9 |
2.6 |
GO:0051659 |
maintenance of mitochondrion location(GO:0051659) |
| 0.9 |
1.7 |
GO:2000019 |
negative regulation of male gonad development(GO:2000019) |
| 0.9 |
10.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 |
2.6 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.9 |
5.2 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.9 |
0.9 |
GO:0034443 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.9 |
6.0 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.9 |
0.9 |
GO:0042488 |
positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
| 0.8 |
6.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.8 |
4.2 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.8 |
2.5 |
GO:0061193 |
taste bud development(GO:0061193) |
| 0.8 |
9.2 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.8 |
1.7 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.8 |
7.5 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.8 |
2.5 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 0.8 |
6.6 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.8 |
5.8 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.8 |
4.9 |
GO:0034312 |
diol biosynthetic process(GO:0034312) |
| 0.8 |
4.9 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.8 |
0.8 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.8 |
2.4 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.8 |
8.9 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 |
8.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.8 |
2.4 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.8 |
3.2 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.8 |
14.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.8 |
11.1 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.8 |
3.2 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.8 |
15.0 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.8 |
3.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.8 |
2.4 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 0.8 |
3.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.8 |
1.6 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
| 0.8 |
12.4 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.8 |
3.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.8 |
3.9 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.8 |
13.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.8 |
1.5 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.8 |
1.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.8 |
3.8 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.8 |
13.0 |
GO:1902653 |
secondary alcohol biosynthetic process(GO:1902653) |
| 0.8 |
7.6 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.8 |
6.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.8 |
4.5 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.8 |
3.8 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.8 |
2.3 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.8 |
32.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.8 |
4.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.8 |
3.0 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.8 |
2.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.8 |
5.3 |
GO:1904100 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.8 |
2.3 |
GO:1904456 |
negative regulation of neuronal action potential(GO:1904456) |
| 0.8 |
4.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.7 |
1.5 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.7 |
9.0 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.7 |
8.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.7 |
4.5 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.7 |
9.6 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.7 |
5.2 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.7 |
1.5 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.7 |
2.9 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.7 |
2.2 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.7 |
2.2 |
GO:0035962 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.7 |
18.2 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.7 |
3.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 |
10.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.7 |
1.5 |
GO:0010705 |
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
| 0.7 |
2.2 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.7 |
4.3 |
GO:1903179 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.7 |
2.9 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.7 |
15.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.7 |
0.7 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.7 |
2.2 |
GO:0061090 |
positive regulation of sequestering of zinc ion(GO:0061090) |
| 0.7 |
3.6 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.7 |
12.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.7 |
0.7 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 |
0.7 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.7 |
1.4 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.7 |
5.0 |
GO:0009188 |
ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.7 |
4.2 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.7 |
1.4 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.7 |
16.3 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.7 |
2.8 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.7 |
2.1 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.7 |
6.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.7 |
6.3 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.7 |
3.5 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.7 |
5.6 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.7 |
22.3 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.7 |
20.9 |
GO:0080184 |
response to phenylpropanoid(GO:0080184) |
| 0.7 |
1.4 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) |
| 0.7 |
2.1 |
GO:0009087 |
methionine catabolic process(GO:0009087) |
| 0.7 |
5.5 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.7 |
9.0 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.7 |
3.5 |
GO:0014854 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.7 |
6.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 |
0.7 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.7 |
1.4 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.7 |
6.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.7 |
3.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.7 |
2.7 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.7 |
3.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.7 |
1.4 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.7 |
5.4 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.7 |
6.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.7 |
8.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.7 |
4.7 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.7 |
4.7 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.7 |
1.3 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 |
4.7 |
GO:1904717 |
regulation of AMPA glutamate receptor clustering(GO:1904717) |
| 0.7 |
12.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.7 |
2.7 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.7 |
2.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.7 |
1.3 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.7 |
2.7 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.7 |
11.2 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 |
3.3 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.7 |
7.8 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.7 |
2.0 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.6 |
9.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.6 |
5.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.6 |
3.8 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.6 |
1.3 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.6 |
3.2 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.6 |
22.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.6 |
0.6 |
GO:1902744 |
negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.6 |
30.3 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 |
1.9 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.6 |
1.9 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.6 |
3.2 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.6 |
2.5 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
6.9 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.6 |
3.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.6 |
5.6 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.6 |
3.8 |
GO:0032824 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.6 |
2.5 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.6 |
5.0 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
2.5 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 |
1.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.6 |
3.1 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.6 |
1.9 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.6 |
11.7 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.6 |
0.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.6 |
3.1 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.6 |
2.5 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.6 |
23.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
9.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.6 |
6.1 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.6 |
1.2 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.6 |
2.4 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.6 |
3.6 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.6 |
1.2 |
GO:0044800 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.6 |
1.2 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.6 |
2.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.6 |
1.8 |
GO:0070194 |
synaptonemal complex disassembly(GO:0070194) |
| 0.6 |
3.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.6 |
0.6 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.6 |
1.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.6 |
5.9 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.6 |
1.8 |
GO:1903093 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.6 |
4.7 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.6 |
1.8 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.6 |
8.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.6 |
1.7 |
GO:0046108 |
uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
| 0.6 |
1.2 |
GO:1902093 |
positive regulation of sperm motility(GO:1902093) |
| 0.6 |
0.6 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.6 |
31.7 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.6 |
4.0 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.6 |
2.9 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.6 |
10.9 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.6 |
1.7 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.6 |
6.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 |
2.3 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.6 |
0.6 |
GO:0061550 |
cranial ganglion development(GO:0061550) |
| 0.6 |
2.9 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.6 |
1.7 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.6 |
2.3 |
GO:0046226 |
coumarin catabolic process(GO:0046226) |
| 0.6 |
2.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.6 |
1.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 |
0.6 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.6 |
2.3 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.6 |
2.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.6 |
3.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.6 |
0.6 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.6 |
4.0 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.6 |
3.4 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.6 |
5.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.6 |
0.6 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.6 |
2.2 |
GO:0034651 |
cortisol biosynthetic process(GO:0034651) |
| 0.6 |
2.2 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.6 |
0.6 |
GO:1900116 |
sequestering of extracellular ligand from receptor(GO:0035581) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.6 |
2.8 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.6 |
5.0 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.6 |
7.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.6 |
5.0 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.6 |
1.1 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.6 |
0.6 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.6 |
1.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.6 |
1.1 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.5 |
1.6 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.5 |
12.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.5 |
1.1 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) embryonic nail plate morphogenesis(GO:0035880) |
| 0.5 |
2.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.5 |
2.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.5 |
2.2 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.5 |
17.3 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.5 |
6.5 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.5 |
1.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.5 |
2.1 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.5 |
1.6 |
GO:2000437 |
regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 0.5 |
5.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 |
1.1 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.5 |
3.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.5 |
2.1 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.5 |
3.7 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.5 |
3.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 |
4.8 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.5 |
2.1 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.5 |
1.6 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.5 |
4.7 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.5 |
2.6 |
GO:0046449 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.5 |
2.1 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 0.5 |
0.5 |
GO:0021843 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.5 |
2.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
| 0.5 |
1.6 |
GO:0031283 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.5 |
19.8 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.5 |
4.7 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.5 |
13.0 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.5 |
1.6 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 |
1.6 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.5 |
3.1 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.5 |
1.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.5 |
10.3 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.5 |
2.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
2.6 |
GO:0048242 |
epinephrine secretion(GO:0048242) |
| 0.5 |
0.5 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.5 |
0.5 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.5 |
2.5 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.5 |
2.0 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.5 |
0.5 |
GO:0009955 |
adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
| 0.5 |
3.5 |
GO:0051611 |
regulation of serotonin uptake(GO:0051611) |
| 0.5 |
1.5 |
GO:0051885 |
positive regulation of anagen(GO:0051885) |
| 0.5 |
2.0 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.5 |
1.0 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.5 |
13.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.5 |
2.0 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.5 |
1.0 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.5 |
3.4 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.5 |
4.9 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.5 |
1.5 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 |
2.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.5 |
1.4 |
GO:0033577 |
protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.5 |
9.6 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.5 |
2.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.5 |
1.4 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.5 |
1.4 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.5 |
1.9 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.5 |
4.3 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.5 |
1.4 |
GO:0006067 |
ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
| 0.5 |
0.9 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 |
0.9 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.5 |
1.4 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.5 |
0.5 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.5 |
1.4 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.5 |
1.9 |
GO:1904616 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.5 |
0.9 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 |
4.7 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.5 |
1.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.5 |
7.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.5 |
2.3 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.5 |
1.8 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.5 |
0.9 |
GO:2000556 |
regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
| 0.5 |
0.9 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.5 |
3.7 |
GO:0002568 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.5 |
1.4 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.5 |
3.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.5 |
1.4 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
3.6 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 |
1.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 |
0.4 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.4 |
5.8 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 |
1.3 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 |
2.2 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.4 |
0.9 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.4 |
1.3 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 |
11.5 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.4 |
0.4 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.4 |
4.0 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.4 |
11.9 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.4 |
0.4 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.4 |
0.4 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.4 |
0.9 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.4 |
3.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.4 |
2.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
1.3 |
GO:0001982 |
baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
| 0.4 |
2.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 |
7.8 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.4 |
0.9 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.4 |
3.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.4 |
1.7 |
GO:1904566 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.4 |
0.9 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.4 |
2.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.4 |
1.7 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.4 |
2.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.4 |
0.4 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.4 |
8.5 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.4 |
2.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 |
1.7 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.4 |
3.0 |
GO:0007527 |
adult somatic muscle development(GO:0007527) |
| 0.4 |
2.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
6.3 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.4 |
2.5 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.4 |
13.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
2.9 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.4 |
1.7 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 |
6.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
11.6 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.4 |
2.1 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.4 |
2.1 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.4 |
0.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.4 |
4.5 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.4 |
3.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.4 |
1.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.4 |
1.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.4 |
1.6 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.4 |
0.8 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.4 |
4.9 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.4 |
2.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.4 |
0.8 |
GO:0035766 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.4 |
2.0 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.4 |
0.4 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.4 |
2.0 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.4 |
0.4 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.4 |
2.8 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.4 |
0.8 |
GO:0002930 |
trabecular meshwork development(GO:0002930) dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.4 |
0.8 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.4 |
1.2 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.4 |
0.4 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.4 |
1.6 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.4 |
0.4 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.4 |
0.8 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 |
1.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.4 |
1.5 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.4 |
1.9 |
GO:1902163 |
negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
| 0.4 |
6.9 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.4 |
1.9 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.4 |
1.5 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.4 |
2.3 |
GO:0007350 |
blastoderm segmentation(GO:0007350) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.4 |
3.0 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.4 |
2.7 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
10.3 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.4 |
0.4 |
GO:1904528 |
positive regulation of microtubule binding(GO:1904528) |
| 0.4 |
2.3 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 |
1.5 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.4 |
3.0 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 |
18.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.4 |
1.9 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.4 |
1.9 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 |
0.7 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.4 |
1.1 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.4 |
1.5 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.4 |
10.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.4 |
0.4 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) |
| 0.4 |
0.7 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.4 |
4.8 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.4 |
0.4 |
GO:0002461 |
tolerance induction dependent upon immune response(GO:0002461) |
| 0.4 |
1.1 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.4 |
6.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.4 |
5.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.4 |
1.8 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.4 |
4.4 |
GO:0099625 |
ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.4 |
1.5 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.4 |
3.3 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.4 |
3.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.4 |
4.4 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.4 |
1.1 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.4 |
2.2 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.4 |
0.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 |
1.4 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.4 |
1.4 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.4 |
1.4 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.4 |
5.7 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
1.8 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 |
1.8 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.4 |
3.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.4 |
2.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.4 |
10.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.3 |
1.4 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.3 |
4.9 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
1.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 |
2.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
2.1 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
1.4 |
GO:0044208 |
AMP biosynthetic process(GO:0006167) 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 |
0.3 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.3 |
6.6 |
GO:0048490 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 |
2.8 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.3 |
0.3 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.3 |
0.3 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.3 |
2.4 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.3 |
4.4 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.3 |
1.0 |
GO:1900477 |
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
| 0.3 |
1.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.3 |
2.0 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.3 |
0.7 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.3 |
1.3 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 |
0.7 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
4.3 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
2.6 |
GO:0042637 |
catagen(GO:0042637) |
| 0.3 |
2.0 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.0 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
4.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.3 |
0.3 |
GO:0072174 |
metanephric tubule formation(GO:0072174) |
| 0.3 |
4.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 |
7.8 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.3 |
0.7 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.3 |
1.9 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.3 |
2.9 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.3 |
1.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 |
1.9 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.3 |
1.9 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 |
2.9 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.3 |
1.0 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 |
0.3 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.3 |
1.6 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
7.3 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 |
0.9 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.3 |
2.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
1.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 |
2.2 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.3 |
0.9 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.3 |
8.8 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.3 |
0.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
0.6 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
1.9 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
0.6 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
0.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.3 |
2.8 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.3 |
2.5 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.3 |
0.9 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.3 |
1.5 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.3 |
0.9 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.3 |
3.0 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
0.3 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
| 0.3 |
1.2 |
GO:0072423 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.3 |
0.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 |
0.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
2.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 |
2.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.3 |
2.4 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.3 |
0.9 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 |
1.5 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.3 |
0.9 |
GO:0045212 |
neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 |
1.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.3 |
32.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.3 |
0.9 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.3 |
6.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.3 |
1.5 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 |
1.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.3 |
0.6 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.3 |
2.3 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.3 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 |
2.6 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 |
0.9 |
GO:0033082 |
regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.3 |
0.6 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
1.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
1.5 |
GO:0061744 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.3 |
1.2 |
GO:0090156 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 |
0.3 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.3 |
1.7 |
GO:0044851 |
hair cycle phase(GO:0044851) |
| 0.3 |
3.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 |
4.0 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.3 |
1.1 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.3 |
0.6 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.3 |
0.3 |
GO:0090265 |
immune complex clearance by monocytes and macrophages(GO:0002436) monocyte homeostasis(GO:0035702) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
| 0.3 |
0.6 |
GO:0099541 |
trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.3 |
1.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.3 |
1.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
6.2 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.3 |
0.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.3 |
2.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
1.4 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.3 |
4.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.3 |
0.3 |
GO:0098963 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.3 |
1.1 |
GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.3 |
1.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
0.6 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.3 |
0.3 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.3 |
1.4 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.3 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
10.9 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.3 |
3.0 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.3 |
0.8 |
GO:0071469 |
response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
| 0.3 |
3.8 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.3 |
0.3 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
0.5 |
GO:0043382 |
memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
| 0.3 |
0.5 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.3 |
1.9 |
GO:0098596 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.3 |
0.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.3 |
2.7 |
GO:0042953 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.3 |
5.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.3 |
0.5 |
GO:0072007 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.3 |
0.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
0.8 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 |
0.5 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.3 |
6.3 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.3 |
17.0 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.3 |
3.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
0.5 |
GO:0002780 |
antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
| 0.3 |
3.1 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
1.5 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.3 |
1.3 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 |
1.0 |
GO:0018317 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 |
1.8 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
| 0.3 |
1.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.3 |
0.3 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.3 |
1.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.3 |
7.1 |
GO:0035136 |
forelimb morphogenesis(GO:0035136) |
| 0.3 |
7.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 |
1.5 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.3 |
1.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
2.8 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.3 |
0.8 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.2 |
0.2 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.2 |
1.7 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 |
0.2 |
GO:0002663 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) lung ciliated cell differentiation(GO:0061141) |
| 0.2 |
0.5 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.2 |
0.5 |
GO:0048808 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 |
1.0 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.7 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.2 |
1.5 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.2 |
2.7 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.2 |
0.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.2 |
1.9 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.2 |
GO:0003272 |
endocardial cushion formation(GO:0003272) |
| 0.2 |
5.3 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.2 |
1.7 |
GO:0036296 |
response to increased oxygen levels(GO:0036296) |
| 0.2 |
1.4 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
1.0 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.2 |
1.9 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.7 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.2 |
1.4 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
1.0 |
GO:0009305 |
protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.2 |
0.7 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.2 |
0.9 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
0.2 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.2 |
1.2 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.2 |
0.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
7.0 |
GO:1905145 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 |
2.8 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.2 |
0.7 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
0.9 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
1.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.2 |
1.8 |
GO:0045060 |
negative thymic T cell selection(GO:0045060) |
| 0.2 |
0.5 |
GO:0072033 |
renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.2 |
0.2 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.2 |
0.2 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 |
0.9 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.2 |
0.4 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.2 |
0.9 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 |
1.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
0.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.2 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
| 0.2 |
2.0 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
1.7 |
GO:1900103 |
positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.2 |
0.6 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.2 |
1.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
2.6 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 |
1.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.2 |
1.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.2 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.2 |
0.9 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
1.7 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.2 |
0.6 |
GO:0055093 |
response to hyperoxia(GO:0055093) |
| 0.2 |
0.6 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.2 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.2 |
4.6 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.2 |
0.6 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.2 |
0.6 |
GO:0042746 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, wakefulness(GO:0042746) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.2 |
0.2 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 |
1.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.2 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.2 |
1.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
0.8 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
4.1 |
GO:0032094 |
response to food(GO:0032094) |
| 0.2 |
0.6 |
GO:0042694 |
muscle cell fate specification(GO:0042694) |
| 0.2 |
1.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
0.6 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
8.5 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.2 |
1.8 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
1.2 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 |
2.2 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
2.0 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 |
7.1 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.2 |
3.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.2 |
1.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.2 |
2.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
0.6 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
0.6 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 |
5.4 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.2 |
1.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
1.0 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 |
8.3 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 |
2.1 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
0.8 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 |
2.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
3.6 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 |
9.9 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.2 |
1.5 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
7.2 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.2 |
0.6 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
0.9 |
GO:0035660 |
MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
| 0.2 |
1.1 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.2 |
0.6 |
GO:0021934 |
hindbrain tangential cell migration(GO:0021934) |
| 0.2 |
0.6 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
1.1 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.2 |
0.6 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.6 |
GO:2000224 |
regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
2.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
0.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
1.5 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 |
0.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.2 |
0.2 |
GO:1900228 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.2 |
0.4 |
GO:0071608 |
macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
| 0.2 |
0.7 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.2 |
0.4 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.2 |
0.5 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
0.5 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
3.1 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
0.7 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
1.5 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
3.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
1.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.2 |
0.7 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.2 |
1.4 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
0.2 |
GO:0009216 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) dGDP metabolic process(GO:0046066) |
| 0.2 |
1.7 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 |
4.4 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
2.2 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.2 |
0.5 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.2 |
0.3 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
| 0.2 |
1.5 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
0.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
2.0 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
7.8 |
GO:0046426 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 |
0.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.2 |
1.9 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.2 |
1.5 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
0.8 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.2 |
0.8 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
4.8 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.2 |
1.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
0.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
2.5 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 |
0.9 |
GO:0042748 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.2 |
3.3 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 |
2.8 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.2 |
0.5 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
1.2 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.2 |
0.8 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
5.3 |
GO:0032012 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
0.3 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.1 |
1.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.6 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.1 |
13.6 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.1 |
2.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
7.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.9 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
2.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.6 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.3 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
1.4 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.6 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
1.3 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.1 |
0.7 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 |
1.8 |
GO:0032823 |
regulation of natural killer cell differentiation(GO:0032823) |
| 0.1 |
0.3 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
2.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.4 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
1.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
4.3 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
0.1 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.4 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.1 |
0.4 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
1.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.9 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
1.9 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
2.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.1 |
GO:0051462 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
| 0.1 |
1.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.4 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
1.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
1.0 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
2.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.4 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
7.6 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.8 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 |
1.9 |
GO:0016101 |
diterpenoid metabolic process(GO:0016101) |
| 0.1 |
0.9 |
GO:2001180 |
negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 |
1.0 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
1.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.5 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
0.5 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.1 |
0.5 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.1 |
0.9 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
2.1 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.6 |
GO:0032049 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
1.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.8 |
GO:0009164 |
nucleoside catabolic process(GO:0009164) |
| 0.1 |
0.5 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.8 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.7 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
3.1 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.1 |
0.3 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.1 |
0.7 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.2 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
1.0 |
GO:0042491 |
hair cell differentiation(GO:0035315) auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
2.3 |
GO:0035812 |
renal sodium excretion(GO:0035812) |
| 0.1 |
2.1 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.1 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.4 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.5 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.2 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.1 |
0.3 |
GO:0035696 |
monocyte extravasation(GO:0035696) |
| 0.1 |
0.2 |
GO:0072148 |
epithelial cell fate commitment(GO:0072148) |
| 0.1 |
0.3 |
GO:0035872 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
| 0.1 |
0.3 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.3 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.1 |
0.5 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.5 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
4.4 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.1 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
1.0 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.4 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.6 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.2 |
GO:0046533 |
regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.1 |
0.2 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.4 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.3 |
GO:0035522 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.4 |
GO:0042133 |
neurotransmitter metabolic process(GO:0042133) |
| 0.1 |
0.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
1.1 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.3 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.2 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.1 |
0.3 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 |
0.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 |
0.4 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.1 |
0.3 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.1 |
8.9 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.2 |
GO:0002838 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
| 0.1 |
0.8 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.7 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.4 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 |
0.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.1 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.6 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.2 |
GO:0010710 |
regulation of collagen catabolic process(GO:0010710) |
| 0.1 |
3.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.8 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.1 |
0.4 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 |
1.7 |
GO:0007040 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
0.2 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
0.5 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.2 |
GO:0014862 |
regulation of the force of skeletal muscle contraction(GO:0014728) regulation of skeletal muscle contraction by chemo-mechanical energy conversion(GO:0014862) |
| 0.1 |
1.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.1 |
0.3 |
GO:0060396 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.2 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
1.2 |
GO:1901264 |
carbohydrate derivative transport(GO:1901264) |
| 0.1 |
0.2 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
0.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.8 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
0.4 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.6 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.1 |
0.3 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.4 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.1 |
0.2 |
GO:0003203 |
endocardial cushion morphogenesis(GO:0003203) |
| 0.1 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 |
0.6 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.1 |
0.5 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 |
0.2 |
GO:1990168 |
protein K29-linked deubiquitination(GO:0035523) protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 |
0.9 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.5 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.1 |
0.7 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.5 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 |
0.3 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 |
0.1 |
GO:0003420 |
growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.1 |
0.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
1.2 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
0.5 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.5 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.4 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
0.4 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.2 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.1 |
0.2 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.6 |
GO:1900004 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 |
0.4 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
1.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.2 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.3 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.1 |
GO:0008207 |
C21-steroid hormone metabolic process(GO:0008207) |
| 0.1 |
0.2 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.1 |
1.9 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.1 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.1 |
GO:1901317 |
regulation of sperm motility(GO:1901317) |
| 0.1 |
0.4 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.2 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.3 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 0.0 |
0.2 |
GO:0010894 |
negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
| 0.0 |
0.0 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.3 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.6 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.3 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.0 |
0.7 |
GO:0032309 |
icosanoid secretion(GO:0032309) |
| 0.0 |
0.1 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.0 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.0 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.0 |
0.2 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.0 |
0.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.3 |
GO:0019217 |
regulation of fatty acid metabolic process(GO:0019217) |
| 0.0 |
0.1 |
GO:0002786 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 |
0.1 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.0 |
0.1 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.0 |
0.1 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.0 |
GO:1902276 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
| 0.0 |
0.4 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.0 |
0.1 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.0 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.0 |
0.3 |
GO:2000576 |
positive regulation of microtubule motor activity(GO:2000576) |
| 0.0 |
0.2 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.1 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.0 |
0.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.0 |
GO:0036394 |
amylase secretion(GO:0036394) |
| 0.0 |
0.7 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.0 |
GO:0052422 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 |
0.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.0 |
GO:1903999 |
regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.0 |
0.1 |
GO:0040023 |
nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.1 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
